Mydecine Receives Conditional IRB Approval for Phase 2b Smoking Cessation Study

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/21/2026

1. TGT
2. EL
3. WMT
4. SPY
5. ROST
6. ADI
7. BILL
8. MRNA
9. NTES
10. SPCX

Go back to Mydecine Receives Conditional IRB Approval for Phase 2b Smoking Cessation Study
(NASDAQ: MYCO) Delayed: 23.94 --0 (-0%)
Previous Close $23.94    52 Week High $ 
Open $23.94    52 Week Low $ 
Day High $23.94    P/E N/A 
Day Low $23.94    EPS $ 
Volume 2,350       

(AMEX: MYCOF) Delayed: 0.73 --0 (-0%)
Previous Close $0.73    52 Week High $ 
Open $0.73    52 Week Low $ 
Day High $0.73    P/E N/A 
Day Low $0.73    EPS $ 
Volume 784